Austria
21
Jan 2021
The Austrian Institute for Health Technology Assessment (AIHTA) completed a research project, “Lung cancer screening in risk groups: Systematic reviews of effectiveness and utility (part 1) and costs and budgetary consequences (part 2),” and published the reports in the mid of December 2020.
Read more
24
Dec 2020
The Austrian Institute for Health Technology Assessment (AIHTA) completed the research project “Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples”. The report was published in the middle of December 2020.
Read more
10
Nov 2020
The Austrian Institute for Health Technology Assessment (AIHTA) is conducting a research project “Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples”. The project started in May 2020, with expected completion in November 2020.
Read more
16
Oct 2020
In late September 2020, the Austrian version of the DRG system (LKF) 2021 model with the relevant supplementary documents was published in Austria. For 2021, the main changes include the addition of sixteen new procedure codes and the introduction of two new procedure codes for billing in the day-case settings, update of cases flat rates, and adjustments of the cases daily component calculation.
Read more
22
Sep 2020
Earlier in September 2020, the Austrian Institute for Health Technology Assessment (AIHTA) released a synopsis of the ongoing research project “Reimbursement decisions for medical procedures in Austria: An analysis of factors – besides clinical evidence – influencing reimbursement decisions for the hospital benefit catalog 2010-2020.”
Read more
02
Sep 2020
In July 2020, the Austrian Institute for Health Technology Assessment (AIHTA) issued an updated report on the PET/PET-CT evidence for need-based planning in Austria.
Read more
25
Aug 2020
In July 2020, the Austrian Institute for Health Technology Assessment (AIHTA) published updated evaluations of medical procedures previously assessed. Technologies that were revised are leadless pacemaker for right ventricle pacing and extracorporeal cytokine hemadsorption therapy in patients with sepsis or SIRS.
Read more
11
Aug 2020
In July 2020, the Austrian Institute for Health Technology Assessment (AIHTA) published five decision support documents. The assessed technologies included implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure, intrauterine ultrasound-guided transcervical radiofrequency ablation, percutaneous transvascular implantation of a coronary sinus reducing stent, radiofrequency-induced intravesical chemohyperthermia for non-muscle invasive bladder cancer, and Vascular photodynamic therapy with Padeliporfin (Tookad® solution).
Read more
22
Jul 2020
On June 16, 2020, HTA Austria – Austrian Institute for Health Technology Assessment (AIHTA), issued an updated report on the indications for proton and carbon ion therapy with an overview of confirmed indications, indications that are only recommended under clinical research, and excluded indications.
Read more
30
Jun 2020
In early June 2020, the Austrian Ministry of Health published recommendations for further actions in the establishment of systematic HTA in the Austrian healthcare system, which were developed by the Federal Target Steering Commission in April.
Read more
22
May 2020
Thirteen new MELs (DRGs) were introduced into the LKF 2020 model for the inpatient and outpatient settings.
Read more
18
May 2020
Twenty-five new diagnosis codes were implemented and changed in the Austrian version of ICD-10 2020 of the LKF model 2020
Read more